Cargando…
Effect of cyclic pamidronate administration on osteoporosis in children with β-thalassemia major: a single-center study
BACKGROUND: Osteopenia and osteoporosis represent a prominent cause of morbidity in children with thalassemia. Multiple factors are responsible for the pathogenesis of bone loss in thalassemia, including diabetes, hypothyroidism, parathyroid gland dysfunction, accelerated hemopoiesis, direct iron to...
Autores principales: | El-Hawy, Mahmoud A., Saleh, Nagwan Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348955/ https://www.ncbi.nlm.nih.gov/pubmed/35681246 http://dx.doi.org/10.3345/cep.2019.00535 |
Ejemplares similares
-
Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Lim, Mie Jin, et al.
Publicado: (2010) -
Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Marcuzzi, Annalisa, et al.
Publicado: (2011) -
The Author Response: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Park, Won
Publicado: (2011) -
Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
por: Yoon, Ji-Hee, et al.
Publicado: (2021) -
Cyclic pamidronate treatment for osteogenesis imperfecta: Report from
a Brazilian reference center
por: Pinheiro, Bruna, et al.
Publicado: (2019)